跳至主要内容
临床试验/ACTRN12620001362987
ACTRN12620001362987
已完成
未知

Reducing symptom burden in individuals with irritable bowel syndrome (IBS) and comorbid anxiety or depression: Is a Mediterranean diet intervention feasible?

Deakin University0 个研究点目标入组 59 人2020年12月17日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Irritable Bowel Syndrome
发起方
Deakin University
入组人数
59
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2020年12月17日
结束日期
2022年7月27日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • Inclusion criteria
  • Aged 18\-65 years
  • IBS diagnosis (Rome IV criteria) of any IBS subtype (diarrhea\-predominant, constipation\-predominant, mixed, un\-subtyped)
  • Hospital anxiety and depression score (HADS) subscale score of 8\-14, indicating mild or moderately severe anxiety or depressive symptoms
  • Access to computer and internet access

排除标准

  • Known or suspected major medical conditions
  • Females who report to be pregnant or lactating
  • Unable to follow Mediterranean diet study recommendations (e.g. veganism, lacto\-ovo vegetarians, inability to follow for sociocultural or religious reasons)
  • Co\-existing eating disorder or highly disordered eating
  • Underweight (BMI \<18\.5 kg/m2\) or obesity (\>40 kg/m2\)
  • Change in IBS or anxiety/depression medication or exposure to pre\- or probiotic supplements in the last month or antibiotics or bowel preparation for investigative procedures within the past three months

结局指标

主要结局

未指定

相似试验